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In this work, we propose a method blending representation learning and molec-
ular docking to predict protein ligand interaction, a key building block of drug
repurposing and discovery. Using Leishmaniasis as a case study, we analyze the
speed-accuracy trade-off that representation learning methods provide when com-
pared to more computationally intensive molecular docking methods. We find
that while deep learning methods substantially reduce the screening burden for
molecular docking by a factor of 600, they can not be trusted to find the top lig-
ands binding to a given target. This suggests that current deep learning methods
can be used to come up with a short list of most promising ligands but the final
predictions should rely on molecular docking.
1 INTRODUCTION
Out of the 13,000 existing diseases known in the medical literature, roughly 5,000 have available
treatments with the remaining 8,000 belonging to the rare disease category (Boycott et al., 2013).
By definition, rare diseases affect a smaller or less affluent proportion of the global population and
are not the major targets of pharmaceutical research programs (Feasey et al., 2010).
Many tropical diseases fall in this category. Furthermore, since the 1980s, drug discovery has be-
come slower and more expensive over time, despite improvements in technology. This is known as
Eroom’s law (Scannell et al., 2012).
For neglected tropical diseases, drug repurposing seems like the best avenue to find treatments. Drug
repositioning involves the investigation of existing drugs (1500 approved drugs) or drugs which have
gone through advanced clinical trials for new therapeutic purposes (Pushpakom et al., 2019).
Depending on the approach, finding a new therapeutic use case for a drug involves identifying
molecules (ligands) binding to proteins which are involved in pathway responsible for a symptoms
or associated with the disease vector, be it a parasite or virus. Protein-ligand docking plays a crucial
role in this process (Greenside et al., 2018).
In this work, we use Leishmaniasis as a concrete disease to showcase how deep learning methods
can be paired with molecular simulation methods to accelerate protein-ligand docking.
We present a pipeline for drug repurposing which consists of applying deep learning methods
(Huang et al., 2020) for Drug-Target interaction prediction, followed by the application of Protein-
Ligand Docking with Autodock Vina (Morris et al., 2009).
∗Correspondence to <kanemh@mit.edu>
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We also quantify the agreement between deep learning methods and molecular simulation methods
for protein-ligand prediction. Our main contributions are the quantification of the robustness of
deep learning methods when compared against more established molecular docking methods and




Leishmaniasis depicts a clinical spectrum of diseases caused by a parasitic flagellate protozoan that
infests the blood of various vertebrates including humans by means of a vector usually the female
phlebotomist (Torres-Guerrero et al., 2017). The signs and symptoms vary depending on the species
of Leishmania. Two common forms include cutaneous Leishmaniasis which affects the skin and a
more fetal form visceral leishmaniasis which affects internal organs such as the liver and spleen.
As a neglected tropical disease, Leishmaniasis affects the most vulnerable populations. These pop-
ulations are exposed to costly, prolonged and even toxic treatment despite advances over the years
(Murray et al., 2005). The use of existing (usually approved) drugs to cure these diseases, is a fast
growing field called drug repurposing. Drug repurposing is made more feasible by the use of com-
putational methods. These computational methods are either target or disease based (Sanseau &
Koehler, 2011).
2.2 COMPUTATIONAL METHODS FOR PROTEIN-LIGAND PREDICTION
Molecular docking is a computational procedure that attempts to predict noncovalent binding of
macromolecules or, more frequently, of a macromolecule (receptor) and a small molecule (ligand)
efficiently, starting with their unbound structures, structures obtained from MD simulations, or ho-
mology modeling. Molecular docking is interested in reproducing chemical potentials, which de-
termine the bound conformation preference and the free energy of binding. These methods take
as input the 3D structure of ligands and proteins. The most common software used for molecular
docking are AutoDock Vina, Rosetta Ligand, AutoDock 4 (Meiler & Baker, 2006; Morris et al.,
2009; Trott & Olson, 2010). Molecular docking methods are widely trusted, used and played a role
in the development of the first clinically approved HIV-1 integrase inhibitor (Goodsell et al., 2021;
Schames et al., 2004). More recently, these methods have also been used to identify treatments for
SARS-CoV-2 (Lokhande et al., 2020; Das et al., 2020).
Representation Learning methods on the other hand are more recent and bypass the need for 3D
structures. Through unsupervised and supervised learning, these methods leverage protein and
molecule vectors to predict binding affinity. Protein vectors are represented by either directly extract-
ing features from the amino acid sequence as shown by Reczko & Bohr (1994); Chou (2005); Shen
et al. (2007); Chou (2000); Kim et al. (2019) or using protein language models trained on the task of
next amino acid prediction Alley et al. (2019); Elnaggar et al. (2020); Rives et al. (2019); Heinzinger
et al. (2019). Ligand vectors are represented as either hand-crafted features from SMILES strings
such as in Toropov et al. (2005); Rogers & Hahn (2010); Kim et al. (2019) or graph neural networks
taking as input atoms and their bonds (Gilmer et al., 2017). The protein and ligand representations
are fed to a decoder trained to predict binding affinity.
3 METHODS
3.1 PIPELINE OVERVIEW
In the first part of our pipeline, we computed the affinity scores between targets which characterized
the Leishmaniasis disease and a large list of drugs using DeepPurpose. DeepPurpose introduced by
Huang et al. (2020) is the current state-of-the-art deep learning based method for virtual screening.
Based on the affinity scores obtained from DeepPurpose we shortened the list of drug candidates by
keeping the first 50 drugs for each target. We then select those pairs and compute interface energies
using molecular docking.
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Figure 1: Overview of hybrid deep learning and molecular docking approach for drug repurposing
We started our experiments with data from the Indaba Grand Challenge 1. It consists of a list of ap-
proved drugs (4000+ drugs) and all the known targets (500+ targets) associated with Leishmaniasis.
3.2 MEASURING THE SPEED-ACCURACY TRADE-OFF OF DEEP LEARNING METHODS
A central question of this work is understanding the speed-accuracy trade-off of deep learning meth-
ods. To understand by how much deep learning methods accelerate protein-ligand matching, we
compare the number of CPU hours that would have been required to exhaustively perform protein
ligand docking solely relying on molecular docking software compared to the number of CPU hours
required using our approach.
To understand to what extent deep learning methods agree with molecular docking methods, we
analyzed the correlation between the results of deep learning based methods and computational
molecular docking tool.
Both methods output an affinity score for a given ligand-target pair but have different rules for
ligand appreciation. For DeepPurpose, a higher binding score indicates the ligand is better, while
for Autocking, a lower free energy implies the ligand is better. To compute the correlation of the
scores, for each target, we picked a shortlist of the top 50 drugs according to the deep learning
methods.
For these 50 drugs, we ranked them using scores from Autodock Vina and compared the ranking
correlation between them using the Kendall rank coefficient (Abdi, 2007). The closer the rank
correlation is to 1, the better.
For each target and the top 50 drugs identified by Deep Learning, we also measured the Pearson
correlation between the binding score computed by DeepPurpose and the interface energies from
molecular docking (Benesty et al., 2009). The close the correlation is to -1, the better.
1https://deeplearningindaba.com/grand-challenges/leishmaniasis/
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Min Max Mean
Kendall τ Rank Correlation -0.33 0.10 -0.09
Pearson Correlation -0.30 0.07 -0.12
Table 1: Results of agreements between deep learning and molecular docking methods
Figure 2: Rank assigned by deep learning methods to top drug according to molecular docking
Furthermore, given the nature of this problem, most protein-ligand pairs are irrelevant and the most
important part is coming up with a handful of strong candidate drugs. To take this into account,
we measured the average rank that the top drug according to molecular docking is assigned when
relying on deep learning methods.
4 RESULTS
4.1 DEEP LEARNING IS A POWERFUL TOOL FOR SCREENING BUT A WEAK TOOL FOR
RANKING
The first insight that this work reveals is that deep learning methods are currently weak tool to
perform top drug selection. As can be seen in Table 1, when compared with molecular docking
methods, across targets, the rank and correlation scores are low.
However, when looking at the rank assigned by deep learning methods to the top drug found by
Autodock Vina, we find that the median rank is 32 with a worst rank case of 41. This means that
for all the targets we have tried, the top drug according to molecular docking always will be found
most of the time between position 30 and 40 of the sorted drugs according to deep learning methods.
Exceptionally, it will be in the top 30. Given that the initial ligand library has 4021 ligands, deep
learning methods are able to significantly reduce the space of drug to look at by a factor of 100. That
said, after this initial reduction, they can’t be trusted to exactly identify the top drug.
4.2 A FEW DRUGS CONSISTENTLY COME AT THE TOP
After shrinking the list of drug candidates obtained and predicting ligand target interaction, we
measured how often various drugs were the best to bind to each target. As the disease is characterized
by many targets it is important to find the ligands that will be well bounded with much receptors as
possible. We noticed that top hits were dominated by a few drugs.
As we hypothesized, there are ligands that can be bounded effectively with multiply receptors. These
ligands serve as potential candidate for treatment. As it is shown in the frequency histogram, Fig-
ure 3, the ligand LGAJOMLFGCSBFF-OLXDQKQCSA-N most frequently appears as the top drug
candidate for several targets, hence it can be considered as the most susceptible drug to treat Leish-
maniasis.
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(a) Top 5 (b) Top 1
Figure 3: Frequency of drug’s appearance at the top of the list for each target
4.3 BIOLOGICAL ANALYSIS FOR MOST PROMISING DRUG
Our model predicts the best compound to use as a drug is alpha-glutamicin. It is a non-steroidal anti-
inflammatory drug that adheres to Lipinski’s rule. In addition to its anti-inflammatory actions, it ex-
hibits analgesic, antipyretic, and platelet-inhibitory actions. Its mechanism of action includes block-
ing the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to
cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts
for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute
to their anti-inflammatory effects (PubChem). Furthermore, previous studies have hypotheses that
prostaglandins are parasite virulence factors and play a role in host interactions (Alves-Ferreira et al.,
2020). While the underlying mechanism is yet to be understood, one can hypothesize that blocking
the formation of the substrate, arachidonic acid, required by the parasite to make prostaglandin can
help prevent parasitic action. Based on our model, the best drug-target pair is LGAJOMLFGCSBFF-
OLXDQKQCSA-N and A0A5K1VKU9 with binding energy of -10.7Kcal/mol. Nevertheless, the
chosen compound has negative and similar binding energies with various Leishmania targets making
multi-target attack possible.
4.4 COMPUTATIONAL SPEEDUP: FROM 2 MONTHS TO 14 HOURS
Molecular docking is a traditional method used to compute the configuration of a molecule when
bounded to another. It was de facto methodology and the ground truth for drug discovery.
The dataset used to conduct the screening has 2,058,752 protein-ligand pairs. Given that the majority
of drug-target pairs are irrelevant, screening them is important to focus on the most promising hits.
Using Deep Learning to screen all protein-ligands pairs, we are able to come up with a shortlist of
3400 pairs in which for each target, the top drug matching to it is consistently found. We bring a
computation that would have taken 2 months to 14 hours.
5 CONCLUSION
To conclude, in this work we use Leishmaniasis to understand the role that deep learning methods
can play to accelerate protein ligand prediction. We find that deep learning methods can provide
a reliable shortlist of promising ligands but they can’t be trusted to find the best ligand. Based
on this insight, we present an approach taking advantage of the speedup provided by deep learning
5
Published as a conference paper at ICLR 2021
methods while relying on the accuracy of molecular docking. Future work can extend this analysis to
other diseases and move from molecular docking to experimental characterization of most promising
protein ligand pairs.
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